Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Alcinonide
2. Dermalog
3. Halciderm
4. Halcimat
5. Halog
6. Sq 18,566
7. Sq-18,566
8. Sq18,566
1. 3093-35-4
2. Halciderm
3. Halcimat
4. Halog
5. Halcinonida
6. Sq 18566
7. Si86v6qneg
8. Halcort
9. Sq-18566
10. Nsc-758413
11. So-18566
12. Dsstox_cid_25375
13. Dsstox_rid_80836
14. Dsstox_gsid_45375
15. (1s,2s,4r,8s,9s,11s,12r,13s)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one
16. (4r,8s)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one
17. Sq-18,566
18. Betacorton
19. Halcinonidum
20. Halog-e
21. Ascochrom
22. Volog
23. (1s,2s,4r,8s,9s,11s,12r,13s)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-17-en-16-one
24. Unii-si86v6qneg
25. Halcinonidum [inn-latin]
26. Halcinonida [inn-spanish]
27. Ncgc00016621-01
28. (11?,16?)-21-chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregn-4-ene-3,20-dione
29. Cas-3093-35-4
30. Einecs 221-439-6
31. Prestwick_1069
32. Halog (tn)
33. Brn 1358242
34. Halcinonide [usan:usp:inn:ban:jan]
35. Halcinonide [mi]
36. Prestwick0_000655
37. Prestwick1_000655
38. Prestwick2_000655
39. Prestwick3_000655
40. Halcinonide [inn]
41. Halcinonide [jan]
42. Halcinonide [usan]
43. Halcinonide [vandf]
44. Schembl4335
45. Halcinonide [mart.]
46. Bspbio_000689
47. Halcinonide [usp-rs]
48. Halcinonide [who-dd]
49. 5-19-06-00301 (beilstein Handbook Reference)
50. Mls002153935
51. Halcinonide (jan/usp/inn)
52. Spbio_002610
53. Bpbio1_000759
54. Chembl1200845
55. Dtxsid6045375
56. Chebi:31663
57. Halcinonide [orange Book]
58. Hms1570c11
59. Hms2097c11
60. Hms2230o07
61. Hms3714c11
62. Halcinonide [usp Monograph]
63. 21-chloro-9-fluoro-11.beta.,16.alpha.,17-trihydroxypregn-4-ene-3,20-dione Cyclic 16,17-acetal With Acetone
64. Hy-b0877
65. Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11.beta.,16.alpha.)-
66. Zinc4213474
67. Tox21_110530
68. S4098
69. Akos015962797
70. Tox21_110530_1
71. Ac-1114
72. Ac-1774
73. Ccg-220655
74. Db06786
75. Nsc 758413
76. N6-(trifluoroacetyl)-l-lysyl-l-proline
77. Ncgc00179475-01
78. Ncgc00179475-03
79. 21-chloro-9-fluoro-11beta,16alpha,17-trihydroxypregn-4-ene-3,20-dione Cyclic 16,17-acetal With Acetone
80. As-74757
81. Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
82. Smr001233277
83. So 18566
84. H1672
85. C74589
86. D01308
87. 093h354
88. Q425991
89. Q-201180
90. Brd-k81709173-001-03-8
91. Halcinonide, United States Pharmacopeia (usp) Reference Standard
92. (1s,2s,4r,8s,9s,11s,12r,13s)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]icos-17-en-16-one
93. (4as,4br,5s,6as,6bs,9ar,10as,10bs)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2h-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
94. Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-beta,16-alpha,17-trihydroxy-, Cyclic16,17-acetal With Acetone
95. Pregn-4-ene-3,20-dione,21-chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11b,16a)-
Molecular Weight | 455.0 g/mol |
---|---|
Molecular Formula | C24H32ClFO5 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 454.1922300 g/mol |
Monoisotopic Mass | 454.1922300 g/mol |
Topological Polar Surface Area | 72.8 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 887 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Halog |
PubMed Health | Halcinonide (Topical application route) |
Drug Classes | Adrenal Glucocorticoid, Corticosteroid, Strong |
Drug Label | The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include halcinonide. Halcinonide is designated chemically as 21-Chloro-9-fluoro-11, 16, 1... |
Active Ingredient | Halcinonide |
Dosage Form | Ointment; Cream |
Route | Topical |
Strength | 0.1% |
Market Status | Prescription |
Company | Ranbaxy |
2 of 2 | |
---|---|
Drug Name | Halog |
PubMed Health | Halcinonide (Topical application route) |
Drug Classes | Adrenal Glucocorticoid, Corticosteroid, Strong |
Drug Label | The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include halcinonide. Halcinonide is designated chemically as 21-Chloro-9-fluoro-11, 16, 1... |
Active Ingredient | Halcinonide |
Dosage Form | Ointment; Cream |
Route | Topical |
Strength | 0.1% |
Market Status | Prescription |
Company | Ranbaxy |
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
FDA Label
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07A - Corticosteroids, plain
D07AD - Corticosteroids, very potent (group iv)
D07AD02 - Halcinonide
The precise mechanism of action of topical corticosteroids is unclear. However they possess anti-inflammatory, antipruritic, and vasoconstrictive actions. New research indicates that halcinonide activates MBP (myelin basic protein) expression via smoothened receptor activation. This finding suggests that halcinonide could be used in the treatment of multiple sclerosis therapy as an alternative to Dexamethasone or Methylprednisolone.
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Halcinonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halcinonide, including repackagers and relabelers. The FDA regulates Halcinonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halcinonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Halcinonide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Halcinonide supplier is an individual or a company that provides Halcinonide active pharmaceutical ingredient (API) or Halcinonide finished formulations upon request. The Halcinonide suppliers may include Halcinonide API manufacturers, exporters, distributors and traders.
click here to find a list of Halcinonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Halcinonide DMF (Drug Master File) is a document detailing the whole manufacturing process of Halcinonide active pharmaceutical ingredient (API) in detail. Different forms of Halcinonide DMFs exist exist since differing nations have different regulations, such as Halcinonide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Halcinonide DMF submitted to regulatory agencies in the US is known as a USDMF. Halcinonide USDMF includes data on Halcinonide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Halcinonide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Halcinonide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Halcinonide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Halcinonide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Halcinonide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Halcinonide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Halcinonide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Halcinonide suppliers with NDC on PharmaCompass.
Halcinonide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Halcinonide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halcinonide GMP manufacturer or Halcinonide GMP API supplier for your needs.
A Halcinonide CoA (Certificate of Analysis) is a formal document that attests to Halcinonide's compliance with Halcinonide specifications and serves as a tool for batch-level quality control.
Halcinonide CoA mostly includes findings from lab analyses of a specific batch. For each Halcinonide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Halcinonide may be tested according to a variety of international standards, such as European Pharmacopoeia (Halcinonide EP), Halcinonide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halcinonide USP).
LOOKING FOR A SUPPLIER?